Biorce

Biorce is a Barcelona HealthTech company founded in 2024 that builds Aika, an AI platform for pharmaceutical companies, biotechs and CROs to design and operate clinical trials. Trained on a proprietary foundation of roughly one million trials, Aika supports protocol development, site selection and feasibility analysis while documenting recommendations for regulatory review and keeping experts in the loop; the company says it can reduce preparation timelines and protocol amendments across therapeutic areas including oncology, neurology and rare diseases. In February 2026 Biorce closed a €43.8 million ($52 million) Series A with DST Global Partners, Norrsken VC, YZR Capital, Mustard Seed Maze and angels, bringing total funding to more than €50.6 million ($60 million). Capital supports US expansion, hiring and new contract, budget and planning modules. Source: EU-Startups 2 Feb 2026.